FOOD AND DRUG LAW JOURNAL 2020 SYMPOSIUM: Complimentary for Students
The Food and Drug Law Institute (FDLI), a 501(c)(3) non-profit educational institution, is pleased to host the Food and Drug Law Journal 2020 Symposium, which is complimentary to full-time students.
WHEN: November 12-13 | Virtual Event
Join scholars and practitioners to discuss the federal response to COVID-19 and potential legislative and regulatory changes that might help inform federal agencies’ responses to future pandemics. This year’s two-day virtual academic Symposium includes discussion of thoughtful scholarship from authors on issues such as legislative innovation, the pharmaceutical supply chain, vaccine-related liability, FDA’s One Health initiative, Emergency Use Authorizations, regulation of personal protective equipment, and new diagnostic tests, and other topics.
In collaboration with the Georgetown University Law Center and the O’Neill Institute of Global and National Health Law, this year’s topic, “This Teachable Moment: How COVID-19 Provides Lessons from FDA’s Past and Present That Will Benefit Its Future Preparedness,” takes place on November 12–13 as a completely virtual program. This academic Symposium will focus on the federal response to COVID-19 and potential legislative and regulatory changes that might help inform federal agencies’ responses to future pandemics. Authors will present their papers, followed by commentary from speakers and a moderated discussion.
To sign up, click here.
More information, including the agenda and confirmed speakers, is available on our website.